Ceragon Reports 2026 Third Quarter Financial Results

Ceragon reported Q3 2026 revenue of $95.5 million, up 11.7% year over year, with GAAP operating income rising to $4.5 million from $3.8 million and GAAP net income of $2.4 million versus $28,000 a year earlier. Gross margin increased to 36.0% from 34.3% in Q3 2025, and operating cash flow was $14.1 million. Management updated its 2026 outlook to revenue of $365 million–$375 million and cited opportunities in North America, EMEA and private networks, while noting supply constraints in India.

Analysis

CRNT’s positive Q3 mix and profit trend are less clean than the headline suggests. At the midpoint of full-year revenue and margin guidance, the remaining Q4 implies roughly 31.5% non-GAAP gross margin and 4.3% operating margin—below Q3’s 36.4% and 8.5%, respectively. That points to meaningful margin normalization, so the key near-term question is whether Q3’s software/customer mix repeats, not whether revenue growth continues. Q4 revenue implied by the full-year range is broadly around Q3’s level, rather than a clear acceleration.

Cash conversion also merits a quality discount: Q3 operating cash flow benefited from a $9.5m increase in trade payables, while inventory absorbed $6.4m. Over nine months, cash rose only modestly despite positive operating cash flow, alongside investment spending and debt repayment. India’s 35% revenue share and management’s stated supply constraints make component availability and delivery timing potential swing factors; a supply bottleneck can defer revenue while also limiting favorable mix. Over 1–3 months, the call’s color on backlog, supply normalization, and Q4 mix matters more than the reported quarter. Over 6–18 months, E-band and private-network wins could broaden demand, but these remain management-described opportunities, not demonstrated repeatable economics. Nokia, Ericsson, and Aviat Networks are relevant competitive reference points, but the release provides no share-loss or pricing evidence. Contrarian read: a strong Q3 may prompt extrapolation, while the annual margin outlook itself signals a lower Q4 run rate. Falsify that caution with Q4 guidance/order evidence supporting sustained high mix and margins.

Key Decisions for Investors

• Do not chase CRNT solely on the Q3 beat; treat the full-year margin outlook as the hurdle. Reassess after management clarifies the implied Q4 margin step-down and whether it reflects mix, supply costs, or conservative guidance.
• For existing longs, consider trimming into an outsized post-release rally unless the call supports repeatable software-led mix and confirms that supply constraints are easing without price concessions.
• Set a 1–3 month alert for order/backlog conversion, India component availability, and North American Tier 1 repeat orders. A revenue miss or further reduction in gross-margin outlook would weaken the growth-and-mix thesis.
• Track cash conversion alongside earnings: persistent payable-led operating cash flow or renewed inventory build would undermine the quality of reported improvement; sustained cash generation after working-capital movements would be a positive confirmation.